For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Achieve Life Sciences Inc (NASDAQ: ACHV) was $2.82 for the day, down -1.74% from the previous closing price of $2.87. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 1.77 million shares were traded. ACHV stock price reached its highest trading level at $2.925 during the session, while it also had its lowest trading level at $2.81.
Ratios:
Our analysis of ACHV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 21, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On November 14, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $12.
On September 27, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $20.Raymond James initiated its Strong Buy rating on September 27, 2024, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 04 ’25 when Wan Jerry sold 14,070 shares for $2.77 per share. The transaction valued at 38,974 led to the insider holds 32,694 shares of the business.
KING THOMAS BRAXTON sold 139,858 shares of ACHV for $387,407 on Sep 04 ’25. The Director now owns 315,142 shares after completing the transaction at $2.77 per share. On Sep 04 ’25, another insider, JACOBS CINDY, who serves as the President & CMO of the company, sold 27,629 shares for $2.77 each. As a result, the insider received 76,532 and left with 115,585 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 144116000 and an Enterprise Value of 98679008.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.57, which has changed by -0.3561644 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.31, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is 1.63%, while the 200-Day Moving Average is calculated to be -6.54%.
Shares Statistics:
ACHV traded an average of 1.37M shares per day over the past three months and 1088620 shares per day over the past ten days. A total of 49.69M shares are outstanding, with a floating share count of 42.51M. Insiders hold about 16.67% of the company’s shares, while institutions hold 53.97% stake in the company. Shares short for ACHV as of 1756425600 were 5184657 with a Short Ratio of 3.79, compared to 1753920000 on 2790559. Therefore, it implies a Short% of Shares Outstanding of 5184657 and a Short% of Float of 11.93.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Achieve Life Sciences Inc (ACHV).The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.21 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.13 and -$1.43 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.04, with 6.0 analysts recommending between -$0.6 and -$1.38.
